Jan Walewski

17PUBLICATIONS
129CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Oct 29, 2025
Predictive Value of Baseline Left Ventricular Global Longitudinal Strain for Cardiac Dysfunction in Patients with Moderate to High Risk of Cancer Therapy-Related Cardiovascular Toxicity.

Anna Borowiec, Patrycja Ozdowska, Magdalena Rosinska

|Sep 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Emanuele Zucca, Luca Ceriani, Giovannino Ciccone

|Aug 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone

|Aug 10, 2024
Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients.

Maria Kulecka, Paweł Czarnowski, Aneta Bałabas

|May 07, 2024
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.

Tadeusz Kubicki, Dominik Dytfeld, David Barnidge

Pageof 3

Frequent Collaborators

3 joint publications

Marek Trneny

3 joint publications

Michał Mikula

2 joint publications

Eva Hoster

2 joint publications

Martin Dreyling